Created in 2013 (United States), Syntimmune own 584 sister brands and 17477 competing brands. Syntimmune is a brand of ASTRAZENECA, listed on the stock exchange of London. The ISIN, the company's International Securities Identification Number, is GB0009895292. Syntimmune belongs to the Drug Manufacturers business sector.